|
Dr. Nacy has been in executive management positions in the biotechnology industry for more than 13 years, following a nearly 20 year academic science career. She was Executive Vice President and Chief Scientific Officer at EntreMed, Inc., from 1993 through its successful public offering in June 1996. She left EntreMed in November 1996 and was Chief Scientific Officer for Anergen, Inc., a California company focused on autoimmune diseases, until the company was acquired by Corixa Corporation in December 1998. Dr. Nacy became full time CEO and Chair of the Board of Sequella, Inc. in January 1999. She is a member of the Board of Directors of several for-profit companies and non-profit agencies. Prior to her business experience, she was a career scientist (GS-15) and Science Manager at the Walter Reed Army Institute of Research, Washington, DC (1976-1993). She continues to serve the scientific research community on grant review committees, scientific advisory boards, and as an officer in scientific societies (President, Society for Leukocyte Biology and American Society for Microbiology) Dr. Nacy obtained her A.B., M.A., and Ph.D. in Biology (Microbiology and Immunology) from the Catholic University of America, Washington, DC, and is a Fellow of the American Academy of Microbiology. | 